Clinical Trial Update: POST-CABGDM: Empagliflozin in Perioperative CABG [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated perioperative empagliflozin in patients with type 2 diabetes and coronary artery disease undergoing coronary artery bypass grafting; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Kidney Injury
• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | Phase 4 | Status: COMPLETED